SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-038117
Filing Date
2017-02-10
Accepted
2017-02-10 15:43:32
Documents
2
Group Members
JAMES E. THOMASTHOMAS, MCNERNEY & PARTNERS II, L.P.THOMAS, MCNERNEY & PARTNERS II, LLCTHOMAS, MCNERNEY & PARTNERS, LLCTMP ASSOCIATES II, L.P.TMP ASSOCIATES, L.P.TMP NOMINEE II, LLCTMP NOMINEE, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d345291dsc13da.htm SC 13D/A 180082
2 EX-1 d345291dex991.htm EX-99.1 12020
  Complete submission text file 0001193125-17-038117.txt   193989
Mailing Address 45 S. 7TH ST. SUITE 3060 MINNEAPOLIS MN 55402
Business Address 45 S. 7TH ST. SUITE 3060 MINNEAPOLIS MN 55402 6123358666
THOMAS MCNERNEY & PARTNERS LP (Filed by) CIK: 0001231291 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86177 | Film No.: 17592893
SIC: 2834 Pharmaceutical Preparations